10x Genomics Debuts Range of New Products at AGBT
February 24, 2020 12:00 ET
|
10x Genomics, Inc.
PLEASANTON, Calif., Feb. 24, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG) today announced a broad range of new products at the Advances in Genome Biology and Technology (AGBT) General...
10x Genomics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Full Year 2020 Revenue Guidance
February 18, 2020 16:01 ET
|
10x Genomics, Inc.
PLEASANTON, Calif., Feb. 18, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today reported financial results for the fourth quarter and full year ended December 31, 2019. Recent...
10x Genomics to Report Fourth Quarter and Full Year 2019 Financial Results on February 18, 2020
February 04, 2020 16:05 ET
|
10x Genomics, Inc.
PLEASANTON, Calif., Feb. 04, 2020 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the fourth quarter and full year ended December 31, 2019 after...
10x Genomics to Present at the 38th Annual J.P. Morgan Healthcare Conference
January 07, 2020 16:05 ET
|
10x Genomics, Inc.
PLEASANTON, Calif., Jan. 07, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today announced the company will be participating in the upcoming 38th Annual J.P. Morgan Healthcare...
10x Genomics Begins Shipments of Visium Spatial Gene Expression Solution
November 26, 2019 09:00 ET
|
10x Genomics, Inc.
PLEASANTON, Calif., Nov. 26, 2019 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it has begun shipping its Visium Spatial Gene Expression Solution. The Visium Spatial Gene Expression...
10x Genomics Reports Third Quarter 2019 Financial Results and Provides 2019 Revenue Guidance
November 07, 2019 16:03 ET
|
10x Genomics, Inc.
PLEASANTON, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (Nasdaq: TXG), today reported financial results for the third quarter ended September 30, 2019. Recent Highlights ...
10x Genomics to Report Third Quarter 2019 Financial Results on November 7, 2019
October 25, 2019 16:45 ET
|
10x Genomics, Inc.
PLEASANTON, Calif., Oct. 25, 2019 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced it will report financial results for the third quarter 2019 after market close on Thursday, November...
10x Genomics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
September 16, 2019 16:10 ET
|
10x Genomics, Inc.
PLEASANTON, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- 10x Genomics (Nasdaq: TXG) today announced the closing of its initial public offering of 11,500,000 shares of its Class A common stock, which...
10x Genomics Announces Pricing of Initial Public Offering
September 12, 2019 07:00 ET
|
10x Genomics, Inc.
PLEASANTON, Calif., Sept. 12, 2019 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (“10x Genomics”) today announced the pricing of its initial public offering of its Class A common stock at a price of $39.00...